Citation Tools
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0110 A Phase I Pharmacokinetic Study Comparing SB5, An Adalimumab Biosimilar, And Adalimumab Reference Product (Humira®) in Healthy Subjects
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- FRI0110 A Phase I Pharmacokinetic Study Comparing SB5, An Adalimumab Biosimilar, And Adalimumab Reference Product (Humira®) in Healthy Subjects